FDA inspection
Iovance Biotherapeutics, Inc.: FDA inspection ending Jul 13, 2023
FDA inspection 1210601 · No Action Indicated (NAI) · San Carlos, CA
Key facts
| Inspection ID | 1210601 |
|---|---|
| Firm | Iovance Biotherapeutics, Inc. |
| FEI number | 3027190753 |
| Address | 825 Industrial Rd Ste 400 |
| City | San Carlos |
| State | CA |
| ZIP | 94070 |
| Country | United States |
| Fiscal year | 2023 |
| Inspection end date | Jul 13, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Biologics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- Yes Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data